Search This Blog

Allied Market Research is a global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”.

Follow- on
biologics (FOBs) is a biological, inventor developed product that has greater
similarity to biological products that has been already approved. Both approved
biological medicines and FOBs have no clinical difference when it comes to the
safety as well as potency of the products. The application of FOBs also popular
as biosimilars in blood disorders, Oncology diseases, deficiencies in growth
hormones plus may others, exhibit the greatest market potential as a result of
dynamic patent scenario.

Wider choice
for biologic oncology treatment have now invaded markets including United
States. The arrival of biologic for cancer treatment would help drive low cost
for many of the highly –priced products in patient care. Treatments that worked
as restraint for cancer’s biological substructure have undergone drastic change
for some cancer types. The arrival of biosimilar now accounts for approximately
½ cancer medicine spending up from nearly 11 percent 10 years back reported IMS
Institute. Recently, Hetero pharmaceuticals introduced their biosimilar
medicine Rituximab in India under MABALL found effective in treating blood
cancer.

In another
incident the FDA recognised the first FOBs in the US. The regulatory body
confirmed that the medicine Zarxio can now be used for various chemotherapy
treatments. This drug aids in the production of white bloods cells in a
patient’s body. Besides this, the drug is a generic make of the Neupogen. Apart
from this absence of cost effective drug in the GHD treatment market also
signifies great opportunity, because the latest biologics popular as biobetters
is costly.

Today, FOBs
are being used to a greater extent in NHS. Similarly, NICE also comprises of
biosimilars in its new technology which is an appraisal on somatropin. Health
professionals believe that the biosimilar drugs for hormonal deficiency would
be highly accessible and become popular over the next four to five years
Biosimilars provide NHS significant cost saving, majorly as they are effective
for treating long – term medical conditions.

AlliedMarket Research has published a report titled “World
Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 –
2020.” As per the report the FOBs industry would register a growth of nearly
49.1 percent during the forecast period 2014 to 2020.

Popular posts from this blog

Over the past few years medical sensors have become smaller. The MEMS (or Microelectrical-mechanical systems) have been popular in medical equipment, from stents to chemosensor. Even the capsule endoscopy systems comes with a miniature camera as well as radio technologies. These systems captures the images of human digestive tract from the inside. Latest discoveries in the data analytics, material science and equipment engineering collectively promise a much smaller and modish sensor. The recent development in miniaturization assures biocompatibility. Medical experts believe that the smaller the system, the less likely it would interfere with the immune mechanism. This is true for capsule endoscopy used to take images of the entire gastrointestinal tract. PillCam® SB launched by Covidien boasts of vitamin –sized, wireless pill design that can improve the diagnosis for small bowel diseases. Recently, a Vanderbilt University engineer, Pietro Valdastri received $1.5 million as grant to c…

Contactless
Payments Market by Device Type and Industry Vertical: Global
Opportunity Analysis and Industry Forecast, 2017-2023, the global contactless
payments market was valued at $6,734 million in 2016, and is projected to reach
at $25,565 million by 2023, growing at a CAGR of 21.2% from 2017 to 2023. In
2016, the mobile devices segment accounted for the highest revenue share in the
contactless payments market.

Consumers as well as enterprises have increasingly adopted
number of ways for convenient and secure payments. One of such medium is a
contactless system that has revolutionized the retail and transportation
industries in the past few years. Get the PDF brochure of this market
insight: https://www.alliedmarketresearch.com/request-sample/2513
The global contactless payments market is driven by
convenience in processing low-value payments, increased revenue opportunities,
and reduced transaction time. However, high costs involved for the deployment
of EPOS terminals and lack of t…